Leachables from Saline-Containing IV Bags Can Alter Therapeutic Protein Properties
- 617 Downloads
To investigate the cause of the observed instability of dulanermin in 100 ml polyolefin (PO) infusion bags containing saline.
Diluted dulanermin in IV bags was collected and frozen prior to analysis by size exclusion chromatography. The UV absorption profiles of the IV bag solutions were characterized by using spectrophotometry. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) measured the metal content. Leachables from IV bags were identified by LC-UV-high resolution MS/MS analysis.
An elevated loss of dulanermin monomers was observed only in 100 ml PO bags. These IV bag solutions have a compound that contains zinc and has absorbance at 320 nm. This compound was identified to be 2-Mercaptobenzothiazole, and its zinc salt and was found to come from the stopper used in the 100 ml PO bags. The manufacturer has subsequently corrected this problem by using non-latex components in the 100 ml PO IV bag.
End-users need to be aware that IV bags made from a particular polymer by the same manufacturer may contain components or use a manufacturing process that results in a different product. Analysis of samples after freezing and thawing proved to be useful in identifying potential incompatibility of dulanermin in the IV bags.
KEY WORDScompatibility freeze and thawing dulanermin IV infusion bags leachables
centralized intravenous additive service
Inductively Coupled Plasma
sodium dodecyl sulfate
The authors wish to thank Heather Flores, Bruce Kabakoff and Sherry Martin-Moe for their support of this project.
- 1.Best practice for ONIDP pharmaceutical development programs leachables and extractables. II. ONIDP container closure systems. Leachables and extractables working group, Product Quality Research Institute PQRI training course, Chicago (2007).Google Scholar
- 10.Desai N, Shah SM, Koczone J, Vencl-Joncic M, Sisto C, Ludwig SA. Zinc content of commercial diluents widely used in drug admixtures prepared for intravenous infusion. Inter J Pharm Compd. 2007;11:426–32.Google Scholar
- 11.Ambados F. Incompatibility between aminophylline and element zinc injections. Aust J Hosp Pharm. 1996;26:370–1.Google Scholar
- 15.Chawla AS, Hinberg I. Leaching of plasticizers from and surface characterization of PVC blood platelet bags. Biomater Artif Cells Immobil Biotechnol. 1991;19:761–83.Google Scholar
- 25.Labow RS, Tocchi M, Rock G. A leachable materia from polyolefin bags (abstr.) Presented at 20th International Society Blood Transfusion, Munich (1984 ).Google Scholar
- 32.Flores H, Lin TP, Matthews TC, Pai R, Shahrokh Z. Apo2L ligand/trail formulations. United State Patent Application 20050020498 (2005).Google Scholar
- 33.Lin TP, Shahrokh Z, Flores H, Pai R. Apo2L ligand/trail formulations. United State Patent Application 20050080006 (2005).Google Scholar
- 36.Hecq JD. Ten years of European hospital pharmacy history: centralized intravenous additives services. Eu J Hosp Pharm Sci. 2004;10:47.Google Scholar